Kenneth Carl Anderson

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
4 years
Director since
2023

4 years of board service in total across 1 board, counting each seat separately. Longest: C4 Therapeutics Inc., 3 years.

3 years ยท Since 2023

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jul 1, 2026 C4 Therapeutics Inc. Grant or award +2,650 $4.34 $11,501
Jun 1, 2026 C4 Therapeutics Inc. Option exercise +1,070 $2.11 $2,258
Apr 1, 2026 C4 Therapeutics Inc. Grant or award +4,259 $2.70 $11,499
Jan 2, 2026 C4 Therapeutics Inc. Grant or award +5,958 $1.93 $11,499
Oct 1, 2025 C4 Therapeutics Inc. Grant or award +5,349 $2.15 $11,500
Jul 1, 2025 C4 Therapeutics Inc. Grant or award +7,616 $1.51 $11,500
Apr 1, 2025 C4 Therapeutics Inc. Grant or award +7,841 $1.44 $11,291
Jan 2, 2025 C4 Therapeutics Inc. Grant or award +3,074 $3.66 $11,251
Oct 1, 2024 C4 Therapeutics Inc. Grant or award +2,023 $5.56 $11,248
Jul 1, 2024 C4 Therapeutics Inc. Grant or award +2,320 $4.85 $11,252
Apr 1, 2024 C4 Therapeutics Inc. Grant or award +1,389 $8.10 $11,251
Jan 2, 2024 C4 Therapeutics Inc. Grant or award +1,725 $6.52 $11,247
Oct 2, 2023 C4 Therapeutics Inc. Grant or award +6,617 $1.70 $11,249
Jul 3, 2023 C4 Therapeutics Inc. Grant or award +3,976 $2.83 $11,252
Apr 3, 2023 C4 Therapeutics Inc. Grant or award +3,516 $3.20 $11,251

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.